Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691184 · ClinicalTrials.gov registry record · Phase 1
Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis
A Phase 1 study of Onychomycosis/Onycholysis and Tinea Pedis, sponsored by NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00691184: Completed Phase 1 study of Onychomycosis/Onycholysis and Tinea Pedis, sponsored by NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).
NCT00691184 is a Phase 1 study of Onychomycosis/Onycholysis and Tinea Pedis that has completed, run by NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.). The registered enrollment target is 56 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00691184, a Phase 1 study of Onychomycosis/Onycholysis and Tinea Pedis, has completed, sponsored by NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the safety and pharmacokinetics of 10 % terbinafine hydrogen chloride (HCl) nail lacquer wre investigated by comparison with vehicle control and 1% terbinafine cream
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Terbinafine Hydrochloride
- DRUG Terbinafine
Study Locations (1)
New Jersey
- TKL Research Inc. - Paramus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2005-02 |
| Est. Completion | 2005-12 |
| Phase | Phase 1 |
What the finished NCT00691184 record still lists
NCT00691184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 1 condition, with Onychomycosis/Onycholysis and Tinea Pedis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00691184 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00691184 about?
NCT00691184 is a clinical study titled "Safety and Pharmacokinetics of Terbinafine Hydrogen Chloride (HCl) Nail Lacquer in Patients With Onychomycosis". In this study, the safety and pharmacokinetics of 10 % terbinafine hydrogen chloride (HCl) nail lacquer wre investigated by comparison with vehicle control and 1% terbinafine cream
What is the current status of trial NCT00691184?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2005-02. Estimated completion is 2005-12.
What conditions does trial NCT00691184 study?
This clinical trial studies the following conditions: Onychomycosis/Onycholysis and Tinea Pedis.
What interventions are being tested in trial NCT00691184?
The interventions under investigation include: Placebo (DRUG), Terbinafine Hydrochloride (DRUG), Terbinafine (DRUG).
Who is sponsoring clinical trial NCT00691184?
This trial is sponsored by NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.), which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00691184 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00691184's enrollment target sits among peer trials
56 902nd of 2000 higher than 1,083 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia